FDA approves first MRI-guided focused ultrasound device to treat essential tremor

"U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx> · Mon, 11 Jul 2016 12:05:30 -0500

Title:     FDA approves first MRI-guided focused ultrasound device to treat essential tremor

  You are subscribed to FDA Press Releases for U.S. Food & Drug Administration (FDA).
This information has recently been updated and is now available.

FDA approves first MRI-guided focused ultrasound device to treat essential tremor
07/11/2016 11:28 AM EDT

The U.S. Food and Drug Administration today approved the first focused ultrasound device to treat essential tremor in patients who have not responded to medication. ExAblate Neuro uses magnetic resonance (MR) images taken during the procedure to deliver focused ultrasound to destroy brain tissue in a tiny area thought to be responsible for causing tremors.

.

Manage your FDA Subscriptions:

Update your preferences or unsubscribe

Questions about this service? Please visit subscriberhelp.govdelivery.com

Other inquiries? webmail@xxxxxxxxxx

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332)